French Pharmaceuticals & Biotech Most Popular Stocks

Aelis Farma

Market Cap: €15.0m

A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Poxel

Market Cap: €10.7m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.

NFL Biosciences

Market Cap: €10.7m

A biotechnology company, engages in the development of botanical drugs in France.

Aton

Market Cap: €9.1m

Operates as a bioscience company in France.

Plant Advanced Technologies

Market Cap: €7.6m

A plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France.

TME Pharma

Market Cap: €6.1m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

Oncodesign Precision Medicine Société anonyme

Market Cap: €6.1m

A biopharmaceutical company, engages in the precision medicine business.

Predilife

Market Cap: €5.9m

Designs and markets predictive tests for the occurrence of serious illnesses.

Biophytis

Market Cap: €1.4m

A clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases.

IntegraGen

Market Cap: €1.0m

Provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

Neovacs

Market Cap: €159.1k

A biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France.